Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm.
adverse events
blepharospasm
botulinum toxin
cervical dystonia
hemifacial spasm
movement disorders
treatment utilization
Journal
Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765
Informations de publication
Date de publication:
16 Aug 2024
16 Aug 2024
Historique:
received:
03
07
2024
revised:
12
08
2024
accepted:
13
08
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
28
8
2024
Statut:
epublish
Résumé
Movement disorders such as cervical dystonia, blepharospasm, and hemifacial spasm negatively impact the quality of life of people living with these conditions. Botulinum toxin (BoNT) injections are commonly used to treat these disorders. We sought to describe patient characteristics, BoNT utilization, and potential adverse events (AEs) among patients with cervical dystonia, blepharospasm, and hemifacial spasm using Optum's de-identified Clinformatics
Identifiants
pubmed: 39195772
pii: toxins16080362
doi: 10.3390/toxins16080362
pii:
doi:
Substances chimiques
Botulinum Toxins
EC 3.4.24.69
Neuromuscular Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Merz (Germany)
ID : N/A